Patti Giblin

Company: Revitope Oncology

Job title: VP

Seminars:

Selective Targeting of T Cells to Tumors using Precision TwoGATE™ (Guided Antibody Tumor Engagers) 12:30 pm

Traditional T cell engagers bring T cells in close proximity of tumors and drive potent tumor cell killing. Despite the highly potent nature of these agents, their clinical utility is limited by off-target and on-target/off-tumor toxicities Revitope’s two-component bi-specific TwoGATE ™ platform aims to address these key liabilities by incorporating several design features to more…Read more

day: Day Two